Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Treace Med Cncpt Rg (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
1,86 -2,11 -0,04 615 372
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiTreace Medical Concepts Inc
TickerTMCI
Kmenové akcie:Ordinary Shares
RICTMCI.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 477
Akcie v oběhu k 31.10.2025 63 718 073
MěnaUSD
Kontaktní informace
Ulice100 Palmetto Park Place
MěstoPONTE VEDRA
PSČ32081
ZeměUnited States
Kontatní osobaLynn Lewis
Funkce kontaktní osobyInvestor Relations
Telefon19 043 735 940
Fax19048347169

Business Summary: Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Treace Medical Concepts Inc revenues increased 7% to $150.2M. Net loss decreased 10% to $49.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Medical Equipment, Supplies & Distribution segment loss decrease of 13% to $48.2M.
Odvětvová klasifikace
TRBC2012Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive Officer, FounderJohn Treace5320.05.202501.01.2014
Chief Financial OfficerMark Hair55
Senior Vice President - SalesAaron Berutti46
Chief Legal & Compliance Officer, Corporate SecretaryScot Elder50
Chief Commercial OfficerGaetano Guglielmino55
Chief Innovation OfficerSean Scanlan43